Latest News

 Filter by Provider

The S&P 500 currently sits near its record high despite elevated oil prices, but history says the index would fall sharply during a recession.

Lilly's revenue has soared thanks to its obesity drugs.

Berkshire's now-former billionaire boss and his successor believe in allocating a significant portion of the company's invested capital to their best ideas.

Rivian is zigging while its newest competitor is zagging, and for investors, that's great news.

Now is a great time to buy these stocks that have been cut in half.

Huang warned that isolating China in the AI race could fragment the global ecosystem and weaken U.S. leadership in artificial intelligence.

If you don't know it exists, you can't take advantage of it.

Ray Dalio clarified that his recent note on an imminent "world war" were not a prediction of direct US-China conflict.

Actuate Therapeutics shares surged 14.41% after-hours after Nature Medicine published Phase 2 data showing elraglusib plus chemotherapy improved overall survival in metastatic pancreatic cancer.

US Treasury Secretary Scott Bessent warns growth may slow this quarter due to the Iran war, despite the strong pre-conflict economy.